Our CSO Dr Agapitos Patakas presents our in vitro T cell exhaustion model.
Research often targets the capabilities of T cells, but B cells also hold therapeutic potential.
We’re excited to work with an organisation that empowers Black ethnic minority workers.
Our Senior Study Scientist Dr Luke Muir talks B cells.
We are delighted to share that Antibody Analytics is shortlisted for Scotland’s Life Sciences Business Leadership Award 2024!
This week marks National Apprenticeship Week!
The risk of a brain drain from Scotland is ever present...
Antibody Analytics is pleased to welcome Paul McCluskey as our new Chair of the Board. This appointment follows our recent minority investment from NorthEdge, marking a significant phase in Antibody Analytics’ growth.
In this webinar, we present IndEx-2, our powerful in vitro cell-based platform engineered to modulate the expression of one or two target antigens across a range of biologically relevant levels.
Explore our SPR research poster which investigates the multi-specific modalities of immunotherapeutic molecules.
Antibody Analytics has secured a multi-million-pound investment from NorthEdge. Read on to find out more details.
Explore our research poster as we analyse the data from our new cell line development platform, IndEx-2.